Ovid Therapeutics Inc.OVIDNASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
-97.90%
↓ 146% below average
Average (39q)
211.19%
Historical baseline
Range
High:4724.62%
Low:-100.00%
Volatility
2284.5%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -97.90% |
| Q2 2025 | 4724.62% |
| Q1 2025 | 71.05% |
| Q4 2024 | -56.07% |
| Q3 2024 | 2.37% |
| Q2 2024 | 14.19% |
| Q1 2024 | 4.23% |
| Q4 2023 | 30.28% |
| Q3 2023 | 45.33% |
| Q2 2023 | 13.64% |
| Q1 2023 | 42.61% |
| Q4 2022 | 316.86% |
| Q3 2022 | 0.00% |
| Q2 2022 | -100.00% |
| Q1 2022 | 0.00% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | -100.00% |
| Q1 2021 | 3553.80% |
| Q4 2020 | -17.51% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |